BioBrit — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
BiotechSan Diego, US
Tony Broad(Executive Officer)Francois Ferre(Director)Nick Ecos(Executive Officer, Director)Joseph Markee(Executive Officer, Director)
Hemostemix is a clinical-stage regenerative medicine company developing ACP-01, an investigational autologous (patient-derived) stem cell therapy for vascular and ischemic conditions such as critical limb ischemia, peripheral arterial disease, ischemic cardiomyopathy, and heart failure.
BiotechHealthtechLongevityMedical DevicesBlackfalds
Roger Bergersen(Founder (of predecessor TheraVitae Inc.))Ina Sarel(VP, Research and Development)Kyle Makofka(Chief Restructuring Officer)David Berman(Chief Financial Officer)Angus Jenkins(Director)Don Friesen(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.